Not all sufferers with CLL have to have therapy. Despite all recent advances, the iwCLL still endorses watchful observation for people with asymptomatic sickness.86 This advice relies on not less than two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 The two tr